We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sensitive Estrogen Detection Method Developed

By LabMedica International staff writers
Posted on 13 Jan 2015
The hormone estrogen plays an important role in the human body and has been linked to everything from tumor growth to neuron loss during Alzheimer's disease, but detecting very small amounts of it in blood and other biological fluids can be difficult, especially in the limited amounts available in laboratory studies.

A new method for detecting trace amounts of estrogen has been developed that uses liquid chromatography-mass spectrometry (LC-MS) and tandem mass spectrometry (LC-MS/MS) which remains the most sensitive and specific technique for both quantitative and qualitative analysis of small molecules in biological samples. More...


Scientists at the University of Texas (Arlington, TX, USA) developed a method for ultra-trace determination of estrogens in human serum using a combination of charged bulk derivatization and weak cation exchange (WCX) RAM-based trap-and-elute LC–MS/MS. The LC system was equipped with four pumps (Pump A/B: LC-30AD, Pump C/D: LC-20AD XR), a SIL-30AC AS, and a CTO-30A column oven containing a 2-position six-port switching valve. The analyses have been performed with a prototype WCX RAM trap column (Shimadzu Corporation; Kyoto, Japan). The LC–MS/MS analysis was performed on a Shimadzu LCMS-8050 triple quadrupole mass spectrometer.

Mass spectrometry and chromatography are ways to separate, identify, and quantify molecules in a complex mixture. The process involving liquid chromatography-electrospray ionization-tandem mass spectrometry relies on a vital step called charge derivatization or using a permanently charged reagent to selectively trap the estrogens and isolate them from the lipids and proteins that could interfere with estrogen detection. The limits of detection (LODs) in the study were found to be 3 pg/mL for estriol, 7 pg/mL for estrone and 17α-estradiol, and 5 pg/mL for 17β-estradiol. The new method can be accomplished in less than 25 minutes, including sample preparation and was a sensitive and efficient method for detecting trace amounts at less than 10 parts per trillion in a 100 mL sample.

Jose A. Barrera, PhD, director of the Shimadzu Institute and a coauthor of the study, said, “This new method pushes the detection limit for estrogens to a level that is applicable to research, human health, medicine, and environmental analysis. Its being instituted as a routine service means that all scientists now have the capability to more closely relate research model findings to human health and physiology.” The study was published on November 27, 2014, in the journal Analytica Chimica Acta.

Related Links:

University of Texas
Shimadzu Corporation 



Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.